EdgarLookup

REGENERON PHARMACEUTICALS, INC. — All Filings

1,005 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 13F-HR 144 15-12G 3 4 4/A 424B1 424B3 424B4 424B5 5 8-A12G 8-K 8-K/A ARS CORRESP CT ORDER DEF 14A DEFA14A DEFN14A DEFS14A FWP POS EX PRE 14A PRES14A PX14A6G REGDEX S-3 S-3/A S-3ASR S-8 S-8 POS SC 13D SC 13D/A SC 13G SC 13G/A SC TO-C SC TO-I SC TO-I/A SC TO-T SC TO-T/A SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
144 0001950047-24-001267 Feb 22, 2024
144 0001969223-24-000135 Feb 22, 2024
4 PRIMARY DOCUMENT 0001968202-24-000068 Feb 20, 2024 Feb 15, 2024
4 PRIMARY DOCUMENT 0001968202-24-000066 Feb 16, 2024 Feb 14, 2024
144 0001958244-24-000537 Feb 14, 2024
SC 13G/A SCHEDULE 13G/A 0001104659-24-021814 Feb 13, 2024
4 PRIMARY DOCUMENT 0001968202-24-000064 Feb 13, 2024 Feb 9, 2024
4 PRIMARY DOCUMENT 0001968202-24-000061 Feb 12, 2024 Feb 9, 2024
4 PRIMARY DOCUMENT 0001968202-24-000062 Feb 12, 2024 Feb 8, 2024
4 PRIMARY DOCUMENT 0001968202-24-000058 Feb 9, 2024 Feb 7, 2024
SC 13G/A SEC SCHEDULE 13G 0001422848-24-000245 Feb 9, 2024
144 0001950047-24-000780 Feb 9, 2024
SC 13G/A 0000315066-24-001496 Feb 9, 2024
144 0001969223-24-000075 Feb 9, 2024
144 0001950047-24-000766 Feb 8, 2024
3 OWNERSHIP DOCUMENT 0001104659-24-012275 Feb 8, 2024 Feb 6, 2024
144 0001973141-24-000090 Feb 8, 2024
4 PRIMARY DOCUMENT 0001968202-24-000056 Feb 8, 2024 Feb 7, 2024
144 0001969223-24-000045 Feb 7, 2024
144 0001969223-24-000047 Feb 7, 2024
144 0001969223-24-000050 Feb 7, 2024
4 PRIMARY DOCUMENT 0001968202-24-000054 Feb 6, 2024 Feb 2, 2024
4 PRIMARY DOCUMENT 0001968202-24-000053 Feb 6, 2024 Feb 2, 2024
4 PRIMARY DOCUMENT 0001968202-24-000052 Feb 6, 2024 Feb 5, 2024
10-K 10-K 0001804220-24-000009 Feb 5, 2024 Dec 31, 2023
4 PRIMARY DOCUMENT 0001968202-24-000048 Feb 5, 2024 Feb 1, 2024
144 0001972362-24-000074 Feb 5, 2024
4 PRIMARY DOCUMENT 0001968202-24-000045 Feb 2, 2024 Jan 31, 2024
4 PRIMARY DOCUMENT 0001968202-24-000046 Feb 2, 2024 Feb 1, 2024
8-K 8-K 0001804220-24-000006 Feb 2, 2024
144 0001968582-24-000073 Feb 1, 2024
144 0001950047-24-000554 Feb 1, 2024
8-K FORM 8-K 0001104659-24-008807 Jan 31, 2024 Jan 26, 2024
4 PRIMARY DOCUMENT 0001883850-24-000010 Jan 31, 2024 Jan 30, 2024
144 0001000275-24-000005 Jan 30, 2024
SC 13G/A 0001086364-24-003704 Jan 25, 2024
4 PRIMARY DOCUMENT 0001968202-24-000041 Jan 25, 2024 Jan 23, 2024
4 PRIMARY DOCUMENT 0001968202-24-000042 Jan 25, 2024 Jan 23, 2024
4 PRIMARY DOCUMENT 0001968202-24-000040 Jan 25, 2024 Jan 23, 2024
144 0001950047-24-000420 Jan 23, 2024
4 PRIMARY DOCUMENT 0001968202-24-000036 Jan 18, 2024 Jan 17, 2024
4 PRIMARY DOCUMENT 0001968202-24-000034 Jan 17, 2024 Jan 12, 2024
4 PRIMARY DOCUMENT 0001968202-24-000031 Jan 8, 2024 Jan 4, 2024
8-K FORM 8-K 0001104659-24-002037 Jan 8, 2024
4 PRIMARY DOCUMENT 0001883850-24-000003 Jan 4, 2024 Jan 2, 2024
4 PRIMARY DOCUMENT 0001883850-24-000004 Jan 4, 2024 Jan 2, 2024
4 PRIMARY DOCUMENT 0001883850-24-000005 Jan 4, 2024 Jan 2, 2024
4 PRIMARY DOCUMENT 0001883850-24-000006 Jan 4, 2024 Jan 3, 2024
4 PRIMARY DOCUMENT 0001883850-24-000007 Jan 4, 2024 Jan 2, 2024
4 PRIMARY DOCUMENT 0001883850-24-000008 Jan 4, 2024 Jan 3, 2024